SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

GlaxoSmithKline Consumer Healthcare informs about outcome of board meeting

07 Nov 2019 Evaluate

GlaxoSmithKline Consumer Healthcare has informed that pursuant to Regulation 33 and 30 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, the Board of Directors in its meeting Thursday, November 07, 2019 at 02:00 p.m. at 25th Floor, One Horizon Centre, DLF Phase - V, Golf Course Road, Gurugram - 122002 have considered and taken on record the Unaudited Financial Results for the Quarter and Half Year ended September 30, 2019. The Company is enclosing a copy of the Unaudited Financial Results for the Quarter and Half Year ended September 30, 2019 along with the Limited Review Report, issued by the Auditors for the review done by them.

The above information is a part of company’s filings submitted to BSE.

Glaxo.Cons. Health Share Price

9696.40 0.00 (0.00%)
15-Apr-2020 18:01 View Price Chart
Peers
Company Name CMP
Varun Beverages 446.00
Nestle 1256.30
Britannia Inds 5654.35
LT Foods 412.05
Hatsun Agro Product 937.80
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×